"Long COVID-19" on the Human Brain
NCT05433324 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2025-03-28
Summary
Over one million Canadians have been infected by COVID-19. Many people who have been infected by COVID-19 experience negative mental symptoms, such as "brain fog" and fatigue. For many of these people, they continue to feel these negative mental symptoms even after recovering from COVID-19. However, scientists still do not know how COVID-19 harms the human brain and causes these mental problems. Our goal is to use advanced brain imaging to determine whether people who have been infected with COVID-19 show damage in their brain. We hope that this information will help doctors determine what treatments should be provided to help people who are suffering from continuing mental problems after being infected with COVID-19.
Conditions
- COVID-19
- Long Covid
- Post Acute Sequelae of COVID-19
Interventions
- OTHER
-
MRI and PET Scans
All groups will undergo cognitive tests and brain imaging scans (MRI \& PET)
Sponsors & Collaborators
-
Sunnybrook Health Sciences Centre
collaborator OTHER -
Centre for Addiction and Mental Health
lead OTHER
Principal Investigators
-
Ariel Graff, MD, PhD · Centre for Addiction and Mental Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-05
- Primary Completion
- 2024-11-05
- Completion
- 2024-11-05
Countries
- Canada
Study Locations
More Related Trials
-
Intravenous Ketamine Plus Neurocognitive Training for Depression
NCT03237286 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Modafinil's Effects on Cognition in Remitted MDD
NCT03620253 ·Status: TERMINATED ·Phase: PHASE3
-
Neural Mechanism Underlying Social Cognition in Depressive Patients
NCT03413670 ·Status: UNKNOWN
-
Neuropsychological Sequelae and Long COVID-19 Fatigue
NCT05323318 ·Status: UNKNOWN
-
Anxiety And Depression During COVID-19 IN INDIA
NCT04369300 ·Status: UNKNOWN
-
Neurofilament Light Chain Correlation With Severity of Symptoms and Cognitive Decline in Mood Disorders
NCT06877442 ·Status: NOT_YET_RECRUITING
-
bWell-D Pilot Randomized Controlled Trial
NCT06546917 ·Status: RECRUITING ·Phase: NA
-
Effects of Mindfulness on Brain Functioning in Depressed Patients
NCT05650177 ·Status: COMPLETED ·Phase: NA
-
Brain Inflammation in Major Depressive Disorder Background
NCT01851356 ·Status: COMPLETED
-
Remote Cognitive Remediation for Depression
NCT03492203 ·Status: UNKNOWN ·Phase: NA
-
Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
NCT01962753 ·Status: COMPLETED ·Phase: NA
-
Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms
NCT00844974 ·Status: COMPLETED ·Phase: NA
-
Cognitive Training for Depression
NCT01936506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Suicidality on Social Cognition
NCT06163612 ·Status: RECRUITING
-
Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors
NCT00433238 ·Status: UNKNOWN ·Phase: PHASE1
-
Electrophysiological Correlates of Cognition in Depression
NCT03998748 ·Status: TERMINATED ·Phase: NA
-
DPA-714 and FDG PET/MRI in Depression
NCT06565936 ·Status: RECRUITING ·Phase: NA
-
Investigation of Seasonal Variations of Brain Structure and Connectivity in SAD
NCT03313674 ·Status: COMPLETED ·Phase: NA
-
Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression
NCT03690856 ·Status: UNKNOWN ·Phase: NA
-
Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression
NCT02535390 ·Status: COMPLETED ·Phase: NA
-
Mental and Psychological Problems and Insomnia Disorder of Medical Staff in Hospital With Infected COVID-19 Patients
NCT04978220 ·Status: COMPLETED
-
A Randomized Neuroimaging Trial of Psilocybin in Depression
NCT06072898 ·Status: RECRUITING ·Phase: PHASE2
-
Neurocognition and Work Productivity in Major Depressive Disorder (MDD)
NCT01468610 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Markers and Cognitive Function in Major Depression
NCT01391221 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862
NCT04682769 ·Status: COMPLETED